Subscribe to the Wall Street Grapevine Newsletter Now and Get Free Alerts On Stock Ready To Explode!


By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

VYNE Therapeutics Inc. (NASDAQ:VYNE) Stock Gains Momentum: Jumps 10% in a Month

VYNE Therapeutics Inc. (NASDAQ:VYNE) up 10% in a month. Recently the company established a Scientific Advisory Board comprising leading clinicians and scientists that specialize in inflammatory and immunological diseases. Market Stats On Friday, VYNE stock fell 0.72% at $1.37 with more than 442k shares, compared to its average volume of 898K shares. The stock has …